Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, MDS, adult, Translational Research, epidemiology, Clinical Research, Combination therapy, drug development, Chronic Myeloid Malignancies, Diseases, Therapies, therapy sequence, Myeloid Malignancies, survivorship, Technology and Procedures, Study Population, Human, Minimal Residual Disease , molecular testing
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, MDS, adult, Translational Research, epidemiology, Clinical Research, Combination therapy, drug development, Chronic Myeloid Malignancies, Diseases, Therapies, therapy sequence, Myeloid Malignancies, survivorship, Technology and Procedures, Study Population, Human, Minimal Residual Disease , molecular testing
Saturday, December 10, 2022: 2:00 PM-3:30 PM
291-292
(Ernest N. Morial Convention Center)
Moderators:
Jatinder K. Lamba, PhD, University of Florida, College of Pharmacy, Pharmacotherapy and Translational Re
and
Rong He, MD, Mayo Clinic
Disclosures:
He: Kura Oncology, Inc: Consultancy.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH